Nitroxoline for Prevention and Treatment of Coronavirus Disease
This invention uses 8-hydroxyquinoline derivatives, like Nitroxoline, as effective inhibitors of cathepsin B to block SARS-CoV-2 entry and replication, offering a well-studied, potent antiviral treatment with potential for developing more effective compounds.